SightGlass Vision spectacles control myopia progression for six- and seven-year-olds, according to pivotal clinical trial findings presented at an international conference earlier this week.
Read More
SightGlass Vision specs’ two-year data demonstrates myopia control efficacy
Spectacles that use SightGlass Vision’s trademarked Diffusion Optics Technology have demonstrated efficacy in slowing the progression of myopia in children, based on 24-month interim data from its pivotal multisite clinical study.
Read More
Read More